Literature DB >> 3553241

Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

S W Chang, C O Feddersen, P M Henson, N F Voelkel.   

Abstract

Within 20 min after intraperitoneal injection of Salmonella enteritidis endotoxin in rats, blood platelet-activating factor (PAF) increased from 4.3 +/- 1.3 to 13.7 +/- 2.0 ng/ml (P less than 0.01) and lung PAF from 32.3 +/- 4.9 to 312.3 +/- 19.6 ng (P less than 0.01), but not lung lavage PAF. We tested the effect of PAF receptor antagonists, CV 3988 and SRI 63-441, on endotoxin-induced hemodynamic changes and lung vascular injury. Pretreatment with CV 3988 attenuated systemic hypotension, preserved hypoxic pulmonary vasoconstriction, and prolonged survival of awake catheter-implanted endotoxin-treated (20 mg/kg) rats. Pretreatment with SRI 63-441 prevented the depressed hypoxic pulmonary vasoconstriction after low dose (2 mg/kg) endotoxin. Both CV 3988 and SRI 63-441 blocked the increased extravascular accumulation of 125I-albumin and water in perfused lungs isolated from endotoxin-treated rats. We conclude that PAF is produced in the lung during endotoxemia and may be an important mediator of the systemic and pulmonary hemodynamic changes as well as the acute lung vascular injury after endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553241      PMCID: PMC424426          DOI: 10.1172/JCI112980

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils.

Authors:  J Benveniste
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

2.  Endotoxin and prevention of hypoxic pulmonary vasoconstriction.

Authors:  E K Weir; J Mlczoch; J T Reeves; R F Grover
Journal:  J Lab Clin Med       Date:  1976-12

3.  On-line cardiac output by digital computer.

Authors:  F Huber; I E Sodal; J V Weil
Journal:  J Appl Physiol       Date:  1976-02       Impact factor: 3.531

4.  Estimation of the filtration coefficient of pulmonary exchange vessels.

Authors:  R Drake; K A Gaar; A E Taylor
Journal:  Am J Physiol       Date:  1978-03

5.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

6.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

7.  Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs.

Authors:  I F McMurtry; A B Davidson; J T Reeves; R F Grover
Journal:  Circ Res       Date:  1976-02       Impact factor: 17.367

8.  Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.

Authors:  J A Cook; W C Wise; P V Halushka
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

9.  Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep.

Authors:  R H Demling; M Smith; R Gunther; J T Flynn; M H Gee
Journal:  Am J Physiol       Date:  1981-03

10.  Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  72 in total

1.  Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice.

Authors:  Bodil Petersen; K Frank Austen; Kenneth D Bloch; Yukako Hotta; Fumito Ichinose; Yoshihide Kanaoka; Warren M Zapol
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

Review 2.  The pulmonary physician and critical care. 4. A new look at the pulmonary circulation in acute lung injury.

Authors:  G A Fox; D G McCormack
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

Review 3.  The adult respiratory distress syndrome.

Authors:  N F Voelkel
Journal:  Klin Wochenschr       Date:  1989-06-01

4.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

5.  Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats.

Authors:  S W Chang; N Ohara
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats.

Authors:  X W Qu; R A Rozenfeld; W Huang; S E Crawford; F Gonzalez-Crussi; W Hsueh
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

7.  Effect of tumor necrosis factor receptor binding protein on cell infiltration induced by lipopolysaccharide and Sephadex beads in guinea pig lung.

Authors:  D M Conroy; J N Francischi; P Sirois
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

8.  Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.

Authors:  H Kankaanranta; E Moilanen; H Vapaatalo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

9.  Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

Authors:  Zhili Xu; Jeffrey S Smith; Jie Tian; Andrew P Byrnes
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

10.  Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.

Authors:  M Giral; D Balsa; R Ferrando; M Merlos; J Garcia-Rafanell; J Forn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.